Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v3.22.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock
Common Stock
Private Placement
Common Stock
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Private Placement
Total
Balance at Dec. 31, 2020 $ 41   $ 55,564   $ 116,783,602 $ (802) $ (107,108,664)   $ 9,729,741
Balance (in shares) at Dec. 31, 2020 4,138   5,556,394            
Stock-Based Compensation         216,945       216,945
Issuance of Common Stock in Offerings, Net of Offering Costs   $ 15,311   $ 7,973,550       $ 7,988,861  
Issuance of Common Stock in Offerings, Net of Offering Costs (in shares)   1,531,101              
Issuance of Common Stock from Warrants, Net     $ 104   49,897       50,001
Issuance of Common Stock from Warrants, Net (in shares)     10,417            
Foreign Currency Translation Adjustment           10,473     10,473
Net Loss             (2,010,618)   (2,010,618)
Balance at Mar. 31, 2021 $ 41   $ 70,979   125,023,994 9,671 (109,119,282)   15,985,403
Balance (in shares) at Mar. 31, 2021 4,138   7,097,912            
Balance at Dec. 31, 2021     $ 126,640   135,418,188 (86,431) (120,879,349)   14,579,048
Balance (in shares) at Dec. 31, 2021 7   12,663,965            
Stock-Based Compensation         215,921       215,921
Foreign Currency Translation Adjustment           27,839     27,839
Net Loss             (3,565,014)   (3,565,014)
Balance at Mar. 31, 2022     $ 126,640   $ 135,634,109 $ (58,592) $ (124,444,363)   $ 11,257,794
Balance (in shares) at Mar. 31, 2022 7   12,663,965